Ohtsubo K - Search Results

1

Drug interactions of zonisamide with phenytoin and sodium valproate: serum concentrations and protein binding.

Tasaki K, Minami T, Ieiri I, Ohtsubo K, Hirakawa Y, Ueda K, Higuchi S. Tasaki K, et al. Among authors: ohtsubo k. Brain Dev. 1995 May-Jun;17(3):182-5. doi: 10.1016/0387-7604(95)00032-7. Brain Dev. 1995. PMID: 7573757

2

Influence of additional therapy with zonisamide (Excegran) on protein binding and metabolism of carbamazepine.

Minami T, Ieiri I, Ohtsubo K, Hirakawa Y, Ueda K, Higuchi S, Aoyama T. Minami T, et al. Among authors: ohtsubo k. Epilepsia. 1994 Sep-Oct;35(5):1023-5. doi: 10.1111/j.1528-1157.1994.tb02548.x. Epilepsia. 1994. PMID: 7925145

3

Comparison of single-point phenytoin dosage prediction techniques.

Yukawa E, Higuchi S, Ohtsubo K, Aoyama T. Yukawa E, et al. Among authors: ohtsubo k. J Clin Pharm Ther. 1988 Aug;13(4):293-305. doi: 10.1111/j.1365-2710.1988.tb00196.x. J Clin Pharm Ther. 1988. PMID: 3235480

4

Pharmacokinetic study of valproic acid sustained-release preparation in patients undergoing brain surgery.

Ieiri I, Morioka T, Ichimiya T, Nishio S, Fukui M, Ohtsubo K, Higuchi S. Ieiri I, et al. Among authors: ohtsubo k. Ther Drug Monit. 1995 Feb;17(1):6-11. doi: 10.1097/00007691-199502000-00002. Ther Drug Monit. 1995. PMID: 7725378 Clinical Trial.

5

The effect of 5-(p-hydroxyphenyl)-5-phenylhydantoin (p-HPPH) enantiomers, major metabolites of phenytoin, on the occurrence of chronic side effects: in vivo and in vitro studies.

Ieiri I, Goto W, Hirata K, Toshitani A, Imayama S, Ohyama Y, Yamada H, Ohtsubo K, Higuchi S. Ieiri I, et al. Among authors: ohtsubo k. Psychiatry Clin Neurosci. 1995 Jun;49(3):S247-51. doi: 10.1111/j.1440-1819.1995.tb02192.x. Psychiatry Clin Neurosci. 1995. PMID: 8612160 Clinical Trial. No abstract available.

6

Effect of 5-(p-hydroxyphenyl)-5-phenylhydantoin (p-HPPH) enantiomers, major metabolites of phenytoin, on the occurrence of chronic-gingival hyperplasia: in vivo and in vitro study.

Ieiri I, Goto W, Hirata K, Toshitani A, Imayama S, Ohyama Y, Yamada H, Ohtsubo K, Higuchi S. Ieiri I, et al. Among authors: ohtsubo k. Eur J Clin Pharmacol. 1995;49(1-2):51-6. doi: 10.1007/BF00192358. Eur J Clin Pharmacol. 1995. PMID: 8751021

7

Therapeutic drug monitoring services at Kyushu University Hospital in Japan.

Ieiri I, Higuchi S, Nakao Y, Yukawa E, Ohtsubo K, Yoshikawa M, Aoyama T. Ieiri I, et al. Among authors: ohtsubo k. DICP. 1990 Jun;24(6):629-32. doi: 10.1177/106002809002400614. DICP. 1990. PMID: 2360340

8

Sensitive determination of ambenonium chloride in serum from patients with myasthenia gravis using ion-exchange resin extraction and reversed-phase ion-pair chromatography.

Ohtsubo K, Higuchi S, Aoyama T, Fujii N, Goto I. Ohtsubo K, et al. J Chromatogr. 1989 Nov 24;496(2):397-406. doi: 10.1016/s0378-4347(00)82587-6. J Chromatogr. 1989. PMID: 2613842

9

Influence of food on serum ambenonium concentration in patients with myasthenia gravis.

Ohtsubo K, Fujii N, Higuchi S, Aoyama T, Goto I, Tatsuhara T. Ohtsubo K, et al. Eur J Clin Pharmacol. 1992;42(4):371-4. doi: 10.1007/BF00280120. Eur J Clin Pharmacol. 1992. PMID: 1516600

10

[Evaluation of the intra-hepatic arterial injection therapy of cisplatin (CDDP)-lipiodol suspension in a child with hepatoblastoma].

Ohtsubo K, Mitsuishi T, Higuchi S, Aoyama T, Sue K, Nakagawara A, Ikeda K. Ohtsubo K, et al. Nihon Gan Chiryo Gakkai Shi. 1990 Jan 20;25(1):31-9. Nihon Gan Chiryo Gakkai Shi. 1990. PMID: 2157781 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters